CN103127463B - External Chinese medicine preparation for phlebophlogosis - Google Patents

External Chinese medicine preparation for phlebophlogosis Download PDF

Info

Publication number
CN103127463B
CN103127463B CN201310074393.6A CN201310074393A CN103127463B CN 103127463 B CN103127463 B CN 103127463B CN 201310074393 A CN201310074393 A CN 201310074393A CN 103127463 B CN103127463 B CN 103127463B
Authority
CN
China
Prior art keywords
radix
rhizoma
parts
chinese medicine
curcumae
Prior art date
Application number
CN201310074393.6A
Other languages
Chinese (zh)
Other versions
CN103127463A (en
Inventor
牛玉玲
于芹芹
蒋继芳
谢晓红
刘畅瑞
牛心怡
Original Assignee
枣庄市立医院
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 枣庄市立医院 filed Critical 枣庄市立医院
Priority to CN201310074393.6A priority Critical patent/CN103127463B/en
Publication of CN103127463A publication Critical patent/CN103127463A/en
Application granted granted Critical
Publication of CN103127463B publication Critical patent/CN103127463B/en

Links

Abstract

The invention discloses an external Chinese medicine preparation for phlebophlogosis. The external Chinese medicine preparation is prepared from the traditional Chinese medicine materials in parts by weight of 5-20 parts of pseudo-ginseng, 5-15 parts of root of red-rooted salvia, 10-30 parts of corydalis tuber, 5-30 parts of angelica sinensis, 10-30 parts of radix curcumae, 5-25 parts of curcuma zedoary, 15-30 parts of peach kernel, 15-30 parts of flowers carthami, 15-30 parts of herba lycopi, 8-15 parts of frankincense, 8-15 parts of myrrh, 10-20 parts of corydalis tuber, 15-30 parts of cowherb seed, 10-25 parts of root of common peony, 8-20 parts of achyranthes root, 12-20 parts of ligusticum wallichii, 15-30 parts of radix curcumae longae and 10-30 parts of hematoxylon. The prescription is packaged into a cotton packaging bag after being crushed, and then fished out after being cooked to coat at the part with phlebophlogosis. The external Chinese medicine preparation has a significant treatment effect on the phlebophlogosis, is safe and reliable to treat, free of side effect, simple to operate, economic and practical; the comfort level of a sufferer is improved; and the recurrence rate is reduced.

Description

Phlebitis Traditional Chinese Medicine for external application preparation

Technical field

The present invention relates to one and be used for the treatment of phlebitic Traditional Chinese Medicine for external application preparation.

Background technology

Along vein, move towards to occur that red, swollen, hot, pain is phlebitic main clinical manifestation, phlebitic generation is common with person between twenty and fifty clinically, to patient, has brought painful and very large inconvenience.At present, the phlebitic method of traditional treatment: 5% glucose 250ml+ DANHONG ZHUSHEYE 20.00 ml ivdrip qd, low molecular dextran 30.00g ivdrip qd, low molecular heparin calcium 5000.00iu ih, every day 3-4 time (according to the state of an illness), (10-20 ten thousand is ivdrip qd u) if any thrombosis, to add use NS500ml+ urokinase again.It is just very painful that patient has suffered from phlebitis, and play pin several times every day again, and this has increased misery to patient again, a lot of patients, and therapeutic effect is also not good, repeatedly outbreak.

Summary of the invention

The object of this invention is to provide one and be used for the treatment of phlebitic Traditional Chinese Medicine for external application preparation.

For achieving the above object, the technical solution used in the present invention is:

A kind of phlebitis Traditional Chinese Medicine for external application preparation, is characterized in that: the raw material of Chinese medicine that comprises following parts by weight is made:

Radix Notoginseng 5~20; Radix Salviae Miltiorrhizae 5~15; Rhizoma Corydalis 10~30; Radix Angelicae Sinensis 5~30; Radix Curcumae 10~30; Rhizoma Curcumae 5~25; Semen Persicae 15~30; Flos Carthami 15~30; Herba Lycopi 15~30; Olibanum 8~15; Myrrha 8~15; Rhizoma Corydalis 10~20; King does not stay 15~30; Radix Paeoniae Rubra 10~25; Radix Achyranthis Bidentatae 8~20; Rhizoma Chuanxiong 12~20; Rhizoma Curcumae Longae 15~30; Lignum Sappan 10~30.

According to described phlebitis Traditional Chinese Medicine for external application preparation, it is characterized in that: the raw material of Chinese medicine that increases following weight portion on the basis by described raw material of Chinese medicine is made:

Cortex Moutan 8~20; Radix Arnebiae (Radix Lithospermi) 10~30; Flos Campsis 5~25; Ramulus Euonymi 5~25; Caulis Sargentodoxae 15~30; Rhizoma Polygoni Cuspidati 15~30; Herba Patriniae 10~30; Rhizoma Fagopyri Dibotryis 15~30.

According to described phlebitis Traditional Chinese Medicine for external application preparation, it is characterized in that: described several raw material of Chinese medicine weight portions are:

Radix Notoginseng 10; Radix Salviae Miltiorrhizae 15; Rhizoma Corydalis 15; Radix Angelicae Sinensis 15; Radix Curcumae 10; Rhizoma Curcumae 10; Semen Persicae 16; Flos Carthami 18; Herba Lycopi 16; Olibanum 10; Myrrha 12; Rhizoma Corydalis 15; King does not stay 20; Radix Paeoniae Rubra 12; Radix Achyranthis Bidentatae 15; Rhizoma Chuanxiong 20; Rhizoma Curcumae Longae 15; Lignum Sappan 18.

According to described phlebitis Traditional Chinese Medicine for external application preparation, it is characterized in that: the heavy amount part of described several raw material of Chinese medicine is:

Radix Notoginseng 10; Radix Salviae Miltiorrhizae 15g; Rhizoma Corydalis 15; Radix Angelicae Sinensis 15; Radix Curcumae 10; Rhizoma Curcumae 10; Semen Persicae 15; Flos Carthami 20; Herba Lycopi 16; Olibanum 12g; Myrrha 12; Rhizoma Corydalis 15; King does not stay 20; Radix Paeoniae Rubra 10; Radix Achyranthis Bidentatae 15; Rhizoma Chuanxiong 15; Rhizoma Curcumae Longae 20; Lignum Sappan 20.

According to described phlebitis Traditional Chinese Medicine for external application preparation, it is characterized in that: described several raw material of Chinese medicine weight portions are:

Radix Notoginseng 10; Radix Salviae Miltiorrhizae 15; Rhizoma Corydalis 15; Radix Angelicae Sinensis 15; Radix Curcumae 10; Rhizoma Curcumae 18; Semen Persicae 16; Flos Carthami 20; Herba Lycopi 16g; Olibanum 9; Myrrha 9; Rhizoma Corydalis 15; King does not stay 20; Radix Paeoniae Rubra 10; Radix Achyranthis Bidentatae 15; Rhizoma Chuanxiong 15; Rhizoma Curcumae Longae 15; Lignum Sappan 18.

According to described phlebitis Traditional Chinese Medicine for external application preparation, it is characterized in that: described several raw material of Chinese medicine weight portions are:

Radix Notoginseng 10; Radix Salviae Miltiorrhizae 15; Rhizoma Corydalis 15; Radix Angelicae Sinensis 15; Radix Curcumae 10; Rhizoma Curcumae 10; Semen Persicae 16; Flos Carthami 18; Herba Lycopi 16; Olibanum 10; Myrrha 12; Rhizoma Corydalis 15; King does not stay 20; Radix Paeoniae Rubra 12; Radix Achyranthis Bidentatae 15; Rhizoma Chuanxiong 20; Rhizoma Curcumae Longae 15; Lignum Sappan 18; Cortex Moutan 10; Radix Arnebiae (Radix Lithospermi) 15; Flos Campsis 12g; Ramulus Euonymi 16; Caulis Sargentodoxae 15; Rhizoma Polygoni Cuspidati 18; Herba Patriniae 15; Rhizoma Fagopyri Dibotryis 18.

According to described phlebitis Traditional Chinese Medicine for external application preparation, it is characterized in that: described several raw material of Chinese medicine weight portions are:

Radix Notoginseng 10; Radix Salviae Miltiorrhizae 15; Rhizoma Corydalis 15; Radix Angelicae Sinensis 15; Radix Curcumae 10; Rhizoma Curcumae 10; Semen Persicae 15; Flos Carthami 20; Herba Lycopi 16; Olibanum 12g; Myrrha 12; Rhizoma Corydalis 15; King does not stay 20; Radix Paeoniae Rubra 10; Radix Achyranthis Bidentatae 15; Rhizoma Chuanxiong 15; Rhizoma Curcumae Longae 20; Lignum Sappan 20; Cortex Moutan 12; Radix Arnebiae (Radix Lithospermi) 10; Flos Campsis 15; Ramulus Euonymi 16; Caulis Sargentodoxae 18; Rhizoma Polygoni Cuspidati 20; Herba Patriniae 18; Rhizoma Fagopyri Dibotryis 15.

According to described phlebitis Traditional Chinese Medicine for external application preparation, it is characterized in that: described several raw material of Chinese medicine weight portions are:

Radix Notoginseng 10; Radix Salviae Miltiorrhizae 15; Rhizoma Corydalis 15; Radix Angelicae Sinensis 15; Radix Curcumae 10; Rhizoma Curcumae 18; Semen Persicae 16; Flos Carthami 20; Herba Lycopi 16; Olibanum 9; Myrrha 9; Rhizoma Corydalis 15; King does not stay 20; Radix Paeoniae Rubra 10; Radix Achyranthis Bidentatae 15; Rhizoma Chuanxiong 15; Rhizoma Curcumae Longae 15; Lignum Sappan 18; Cortex Moutan 18; Radix Arnebiae (Radix Lithospermi) 18; Flos Campsis 15; Ramulus Euonymi 15; Caulis Sargentodoxae 16; Rhizoma Polygoni Cuspidati 16; Herba Patriniae 25; Rhizoma Fagopyri Dibotryis 20.

The present invention avoids increasing misery to patient, can treat again disease, for phlebitis patient 60 examples, and with the same period patient 60 example with traditional Therapeutic Method, compare.Through observing contrast, result confirms: phlebitis Traditional Chinese Medicine for external application preparation of the present invention is respond well, has no side effect, and patient is very satisfied, has alleviated the misery that phlebitis and traditional Therapeutic Method bring to patient, and therapeutic effect is good.Phlebitis Traditional Chinese Medicine for external application preparation of the present invention has following beneficial effect: 1, evident in efficacy to phlebitic treatment, treat safe and reliablely, and have no side effect.2, the comfort level that has improved patient, has reduced relapse rate.3, expense is low, has alleviated patient's financial burden.4, simple to operate, economical and practical.5, good economic benefit and social benefit have been obtained.

The specific embodiment

Below in conjunction with specific embodiment, the invention will be further described:

one, phlebitis Traditional Chinese Medicine for external application preparation raw material of Chinese medicine weight proportion of the present invention is:

Radix Notoginseng (5~20 grams); Radix Salviae Miltiorrhizae (5~15g); Rhizoma Corydalis (10~30g); Radix Angelicae Sinensis (5~30g); Radix Curcumae (10~30g); Rhizoma Curcumae (5~25g); Semen Persicae (15~30g); Flos Carthami (15~30g); Herba Lycopi (15~30g); Olibanum (8~15g); Myrrha (8~15g); Rhizoma Corydalis (10~20g); King does not stay (15~30g); Radix Paeoniae Rubra (10~25g); Radix Achyranthis Bidentatae (8~20g); Rhizoma Chuanxiong (12~20g); Rhizoma Curcumae Longae (15~30g); Lignum Sappan (10~30g).

Embodiment 1

Phlebitis Traditional Chinese Medicine for external application preparation raw material of Chinese medicine proportioning weight of the present invention is:

Radix Notoginseng (10 grams); Radix Salviae Miltiorrhizae (15g); Rhizoma Corydalis (15g); Radix Angelicae Sinensis (15g); Radix Curcumae (10g); Rhizoma Curcumae (10g); Semen Persicae (16g); Flos Carthami (18g); Herba Lycopi (16g); Olibanum (10g); Myrrha (12g); Rhizoma Corydalis (15g); King does not stay (20g); Radix Paeoniae Rubra (12g); Radix Achyranthis Bidentatae (15g); Rhizoma Chuanxiong (20g); Rhizoma Curcumae Longae (15g); Lignum Sappan (18g).

Olibanum, Myrrha, Radix Salviae Miltiorrhizae, Rhizoma Corydalis, Radix Paeoniae Rubra, Radix Achyranthis Bidentatae, Semen Vaccariae, Rhizoma Chuanxiong, Radix Angelicae Sinensis, Radix Curcumae, Rhizoma Curcumae Longae, Lignum Sappan etc. in the present invention, have the effect of sedation-analgesia, is used for the treatment of take pain as main phlebitis.

Embodiment 2 (most preferred embodiment )

Phlebitis Traditional Chinese Medicine for external application preparation raw material of Chinese medicine weight proportion of the present invention is:

Radix Notoginseng (10 grams); Radix Salviae Miltiorrhizae (15g); Rhizoma Corydalis (15g); Radix Angelicae Sinensis (15g); Radix Curcumae (10g); Rhizoma Curcumae (10g); Semen Persicae (15g); Flos Carthami (20g); Herba Lycopi (16g); Olibanum (12g); Myrrha (12g); Rhizoma Corydalis (15g); King does not stay (20g); Radix Paeoniae Rubra (10g); Radix Achyranthis Bidentatae (15g); Rhizoma Chuanxiong (15g); Rhizoma Curcumae Longae (20g); Lignum Sappan (20g).

In the present invention, Rhizoma Curcumae Longae, Radix Salviae Miltiorrhizae, Olibanum, Myrrha, Lignum Sappan, Flos Carthami etc. have the effect of blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, for the phlebitis of red, swollen and pain.

Embodiment 3

Phlebitis Traditional Chinese Medicine for external application preparation raw material of Chinese medicine weight of the present invention is:

Radix Notoginseng (10 grams); Radix Salviae Miltiorrhizae (15g); Rhizoma Corydalis (15g); Radix Angelicae Sinensis (15g); Radix Curcumae (10g); Rhizoma Curcumae (18g); Semen Persicae (16g); Flos Carthami (20g); Herba Lycopi (16g); Olibanum (9g); Myrrha (9g); Rhizoma Corydalis (15g); King does not stay (20g); Radix Paeoniae Rubra (10g); Radix Achyranthis Bidentatae (15g); Rhizoma Chuanxiong (15g); Rhizoma Curcumae Longae (15g); Lignum Sappan (18g).

In the present invention, Rhizoma Curcumae, Semen Persicae have the effect of removing blood stasis eliminating stagnation, very good to there being thrombotic phlebitis effect.

when two, the present invention has ulceration, suppuration for phlebitis, then add in order to lower raw material of Chinese medicine (weight):

Cortex Moutan (8~20g); Radix Arnebiae (Radix Lithospermi) (10~30g); Flos Campsis (5~25g); Ramulus Euonymi (5~25g); Caulis Sargentodoxae (15~30g); Rhizoma Polygoni Cuspidati (15~30g); Herba Patriniae (10~30g); Rhizoma Fagopyri Dibotryis (15~30g).

Embodiment 4

Raw material of Chinese medicine proportioning is:

Radix Notoginseng (10 grams); Radix Salviae Miltiorrhizae (15g); Rhizoma Corydalis (15g); Radix Angelicae Sinensis (15g); Radix Curcumae (10g); Rhizoma Curcumae (10g); Semen Persicae (16g), Flos Carthami (18g), Herba Lycopi (16g), Olibanum (10g), Myrrha (12g), Rhizoma Corydalis (15g), Wang Buliu (20g); Radix Paeoniae Rubra (12g); Radix Achyranthis Bidentatae (15g); Rhizoma Chuanxiong (20g); Rhizoma Curcumae Longae (15g); Lignum Sappan (18g); Cortex Moutan (10g); Radix Arnebiae (Radix Lithospermi) (15g); Flos Campsis (12g); Ramulus Euonymi (16g); Caulis Sargentodoxae (15g); Rhizoma Polygoni Cuspidati (18g); Herba Patriniae (15g); Rhizoma Fagopyri Dibotryis (18g).

Embodiment 5

Raw material of Chinese medicine proportioning is:

Radix Notoginseng (10 grams); Radix Salviae Miltiorrhizae (15g); Rhizoma Corydalis (15g); Radix Angelicae Sinensis (15g); Radix Curcumae (10g); Rhizoma Curcumae (10g); Semen Persicae (15g); Flos Carthami (20g); Herba Lycopi (16g); Olibanum (12g); Myrrha (12g); Rhizoma Corydalis (15g); King does not stay (20g); Radix Paeoniae Rubra (10g); Radix Achyranthis Bidentatae (15g); Rhizoma Chuanxiong (15g); Rhizoma Curcumae Longae (20g); Lignum Sappan (20g); Cortex Moutan (12g); Radix Arnebiae (Radix Lithospermi) (10g); Flos Campsis (15g); Ramulus Euonymi (16g); Caulis Sargentodoxae (18g); Rhizoma Polygoni Cuspidati (20g); Herba Patriniae (18g); Rhizoma Fagopyri Dibotryis (15g).

Embodiment 6

Raw material of Chinese medicine proportioning is:

Radix Notoginseng (10 grams); Radix Salviae Miltiorrhizae (15g); Rhizoma Corydalis (15g); Radix Angelicae Sinensis (15g); Radix Curcumae (10g); Rhizoma Curcumae (18g); Semen Persicae (16g); Flos Carthami (20g); Herba Lycopi (16g); Olibanum (9g); Myrrha (9g); Rhizoma Corydalis (15g); King does not stay (20g); Radix Paeoniae Rubra (10g); Radix Achyranthis Bidentatae (15g); Rhizoma Chuanxiong (15g); Rhizoma Curcumae Longae (15g); Lignum Sappan (18g); Cortex Moutan (18g); Radix Arnebiae (Radix Lithospermi) (18g); Flos Campsis (15g); Ramulus Euonymi (15g); Caulis Sargentodoxae (16g); Rhizoma Polygoni Cuspidati (16g); Herba Patriniae (25g); Rhizoma Fagopyri Dibotryis (20g).

three, manufacture method:

After above prescription is pulverized, pack in packaging bag, bag material is selected cotton or non-woven fabrics.Large, medium and small three kinds of models are made in packaging bag, and existing take medium size as example, packaging bag is long × wide is 25 × 15cm.

four, using method:

During the sack that packs medicine into is discharged water, after big fire is boiled, change and simmer in water 10~15 minutes, pull out, temperature is suitable by the time, spreads on phlebitis place, notes avoiding scalding.As low in medicated bag temperature, medicated bag can be put back in the water of original decoct medicinal herbs bag again and be heated, also can cover on medicated bag with preservative film, on preservative film, with 50 ℃ of left and right hot water bag, apply 15~30 minutes.Hot compress every day 3 times, each 20~30 minutes.The water of decoct medicinal herbs can be used for foot bath, drench lower limb.

five, pharmacodynamics test statistics:

The present invention carries out pharmacodynamics test with the raw material of Chinese medicine proportioning of embodiment 2 .

The present invention is for phlebitis patient 60 examples, and with the same period patient's 60 examples with traditional Therapeutic Method, compare.Through observing contrast, result confirms: phlebitis Traditional Chinese Medicine for external application preparation is respond well, has no side effect, and patient is very satisfied, has alleviated the misery that phlebitis and traditional Therapeutic Method bring to patient, and therapeutic effect is good.Now be reported as follows.

Physical data:

Object of study is totally 120 examples (being the phlebitis of lower extremities), by randomized principle, is divided into observation group and matched group.Observation group's 60 examples, male 48 examples, female's 12 examples; Matched group 60 examples, male 43 examples, female's 17 examples.Age: observation group, 21~75 years old, average 42.22 ± 10.60 years old; Matched group, 19~71 years old, average 39.82 ± 9.76 years old.Disease time: the 3h~15d of observation group, average 6.5d; Matched group 4h~12d, average 4.8d; Occupation: observation group, workman's 30 examples, cadre's 21 examples, peasant's 9 examples.Matched group, workman's 31 examples, cadre's 22 examples, peasant's 7 examples.

Two groups of patients' age, disease time, occupation are carried out to t check, and result shows the equal not statistically significant of difference (p>0.05), and two groups have comparability.

Diagnostic criteria:

1, along superficial vein, move towards to occur phlebitis red, hot, pain.

2, B ultrasonic shows: without thrombosis, and the rough phlebitis of blood vessel wall thatch.

3, B ultrasonic shows: there is thrombosis, and with phlebitis hot, swollen, pain.

Therapeutic Method:

Observation group is used a course for the treatment of of Chinese medicine preparation of the present invention (14 days), observe the curative effect; Matched group adopts the phlebitic method of traditional treatment: 5% glucose 250ml+ DANHONG ZHUSHEYE 20.00 ml ivdrip qd, low molecular dextran 30.00g ivdrip qd, (10-20 ten thousand is ivdrip qd u) for NS500ml+ urokinase, low molecular heparin calcium 5000.00iu ih, every day 3 times, treat a course for the treatment of (within 14th, being a course for the treatment of), observe 7 days and one the course for the treatment of curative effect.

Therapeutic outcome:

The effect comparison in 7 days of two groups of patient treatments, the results are shown in Table 1.

Table 1 liang group patient treatment effect comparison in 7 days

Note: X 2=35.29, P < 0.01, through treatment in 7 days, two groups of curative effects had highly significant difference.

Apply Chinese medicine preparation treatment phlebitis of the present invention 60 examples, through treatment in 7 days, cure 26 examples, 32 examples that take a turn for the better, invalid 2 examples, cure rate 43%, total effective rate 96%, learns by statistics and processes (X 2check), observation group's curative effect is apparently higher than matched group (P<0.01).

Through therapeutic effect comparison in 14 days, the results are shown in Table 2.

Table 2 liang group patient treatment effect comparison in 14 days

Note: X 2=12.04, P < 0.01, through treatment in 14 days, two groups of curative effects had highly significant difference.

Through treatment in 14 days, observe, treatment group is always cured 54 examples, 6 examples that take a turn for the better, and cure rate 90%, total effective rate 100%, learns by statistics and processes (X 2check), observation group's curative effect is apparently higher than matched group (P<0.01).

Two groups of patient's comfort level comparisons during treating, the results are shown in Table 3.

Table 3 liang group patient's comfort level comparison during treating (example, percentage ratio %)

Note: X 2 =108.93, p < 0.01,two groups of patients comfort level during treating relatively has highly significant difference.

Apply Chinese medicine preparation treatment phlebitis of the present invention 60 examples, during treatment, comfortable person's 56 examples, more comfortable person's 4 examples, without uncomfortable person, learn by statistics and process (X 2 check), observation group's comfort level is apparently higher than matched group (P<0.01).

Treatment conclusion (advantage):

Phlebitis Traditional Chinese Medicine for external application preparation of the present invention, 1, evident in efficacy to phlebitic treatment, treat safe and reliablely, have no side effect.2, the comfort level that has improved patient, has reduced relapse rate.3, expense is low, has alleviated patient's financial burden.4, simple to operate, economical and practical.5, good economic benefit and social benefit have been obtained.

Claims (4)

1. a phlebitis Traditional Chinese Medicine for external application preparation, is characterized in that: the raw material of Chinese medicine by following parts by weight is made:
Radix Notoginseng 5~20; Radix Salviae Miltiorrhizae 5~15; Rhizoma Corydalis 10~30; Radix Angelicae Sinensis 5~30; Radix Curcumae 10~30; Rhizoma Curcumae 5~25; Semen Persicae 15~30; Flos Carthami 15~30; Herba Lycopi 15~30; Olibanum 8~15; Myrrha 8~15; Rhizoma Corydalis 10~20; King does not stay 15~30; Radix Paeoniae Rubra 10~25; Radix Achyranthis Bidentatae 8~20; Rhizoma Chuanxiong 12~20; Rhizoma Curcumae Longae 15~30; Lignum Sappan 10~30; Cortex Moutan 8~20; Radix Arnebiae (Radix Lithospermi) 10~30; Flos Campsis 5~25; Ramulus Euonymi 5~25; Caulis Sargentodoxae 15~30; Rhizoma Polygoni Cuspidati 15~30; Herba Patriniae 10~30; Rhizoma Fagopyri Dibotryis 15~30.
2. phlebitis Traditional Chinese Medicine for external application preparation according to claim 1, is characterized in that: described raw material of Chinese medicine weight portion is:
Radix Notoginseng 10; Radix Salviae Miltiorrhizae 15; Rhizoma Corydalis 15; Radix Angelicae Sinensis 15; Radix Curcumae 10; Rhizoma Curcumae 10; Semen Persicae 16; Flos Carthami 18; Herba Lycopi 16; Olibanum 10; Myrrha 12; Rhizoma Corydalis 15; King does not stay 20; Radix Paeoniae Rubra 12; Radix Achyranthis Bidentatae 15; Rhizoma Chuanxiong 20; Rhizoma Curcumae Longae 15; Lignum Sappan 18; Cortex Moutan 10; Radix Arnebiae (Radix Lithospermi) 15; Flos Campsis 12; Ramulus Euonymi 16; Caulis Sargentodoxae 15; Rhizoma Polygoni Cuspidati 18; Herba Patriniae 15; Rhizoma Fagopyri Dibotryis 18.
3. phlebitis Traditional Chinese Medicine for external application preparation according to claim 1, is characterized in that: described raw material of Chinese medicine weight portion is:
Radix Notoginseng 10; Radix Salviae Miltiorrhizae 15; Rhizoma Corydalis 15; Radix Angelicae Sinensis 15; Radix Curcumae 10; Rhizoma Curcumae 10; Semen Persicae 15; Flos Carthami 20; Herba Lycopi 16; Olibanum 12; Myrrha 12; Rhizoma Corydalis 15; King does not stay 20; Radix Paeoniae Rubra 10; Radix Achyranthis Bidentatae 15; Rhizoma Chuanxiong 15; Rhizoma Curcumae Longae 20; Lignum Sappan 20; Cortex Moutan 12; Radix Arnebiae (Radix Lithospermi) 10; Flos Campsis 15; Ramulus Euonymi 16; Caulis Sargentodoxae 18; Rhizoma Polygoni Cuspidati 20; Herba Patriniae 18; Rhizoma Fagopyri Dibotryis 15.
4. phlebitis Traditional Chinese Medicine for external application preparation according to claim 1, is characterized in that: described raw material of Chinese medicine weight portion is:
Radix Notoginseng 10; Radix Salviae Miltiorrhizae 15; Rhizoma Corydalis 15; Radix Angelicae Sinensis 15; Radix Curcumae 10; Rhizoma Curcumae 18; Semen Persicae 16; Flos Carthami 20; Herba Lycopi 16; Olibanum 9; Myrrha 9; Rhizoma Corydalis 15; King does not stay 20; Radix Paeoniae Rubra 10; Radix Achyranthis Bidentatae 15; Rhizoma Chuanxiong 15; Rhizoma Curcumae Longae 15; Lignum Sappan 18; Cortex Moutan 18; Radix Arnebiae (Radix Lithospermi) 18; Flos Campsis 15; Ramulus Euonymi 15; Caulis Sargentodoxae 16; Rhizoma Polygoni Cuspidati 16; Herba Patriniae 25; Rhizoma Fagopyri Dibotryis 20.
CN201310074393.6A 2013-03-09 2013-03-09 External Chinese medicine preparation for phlebophlogosis CN103127463B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310074393.6A CN103127463B (en) 2013-03-09 2013-03-09 External Chinese medicine preparation for phlebophlogosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310074393.6A CN103127463B (en) 2013-03-09 2013-03-09 External Chinese medicine preparation for phlebophlogosis

Publications (2)

Publication Number Publication Date
CN103127463A CN103127463A (en) 2013-06-05
CN103127463B true CN103127463B (en) 2014-05-07

Family

ID=48488333

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310074393.6A CN103127463B (en) 2013-03-09 2013-03-09 External Chinese medicine preparation for phlebophlogosis

Country Status (1)

Country Link
CN (1) CN103127463B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103768397B (en) * 2014-02-27 2016-01-20 青岛市市立医院 A kind of medicine for external use for the treatment of the mechanical phlebitis that peripheral central vein retaining tube causes
CN104288672A (en) * 2014-09-09 2015-01-21 青岛市市立医院 Traditional Chinese medicine composition for treating phlebophlogosis and preparation method thereof
CN105169261A (en) * 2015-09-24 2015-12-23 余晓燕 Plaster for treating phlebitis
CN105770534A (en) * 2016-03-31 2016-07-20 山东大学齐鲁医院 External medicine for treating infusion phlebitis
CN107096094A (en) * 2017-07-07 2017-08-29 李宝 A kind of delay pin with function promoting blood circulation and removing blood stasis fixes adhesive plaster

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1151875A (en) * 1995-12-14 1997-06-18 北京海尔富药业有限公司 Chinese medicine prepn
CN101152406A (en) * 2006-09-30 2008-04-02 毕庆双 Externally applied medicine for treating varicosity and phlebitis
CN101455727A (en) * 2007-12-12 2009-06-17 天津市中宝制药有限公司 External application agent for treating phlebitis
CN101607000A (en) * 2009-02-14 2009-12-23 房笑丽 Seven the flavor promote blood circulation hot application and to the transfusion induced phlebitis control
CN101647870A (en) * 2009-09-11 2010-02-17 李红 Traditional Chinese medicine for treating phlebitis caused by chemotherapeutics
CN102671054A (en) * 2012-06-12 2012-09-19 赵国藏 Traditional Chinese medicine composition for treating thrombophlebitis
CN102727641A (en) * 2012-07-13 2012-10-17 孙红梅 External traditional Chinese medicine for treating superficial phlebitis

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1151875A (en) * 1995-12-14 1997-06-18 北京海尔富药业有限公司 Chinese medicine prepn
CN101152406A (en) * 2006-09-30 2008-04-02 毕庆双 Externally applied medicine for treating varicosity and phlebitis
CN101455727A (en) * 2007-12-12 2009-06-17 天津市中宝制药有限公司 External application agent for treating phlebitis
CN101607000A (en) * 2009-02-14 2009-12-23 房笑丽 Seven the flavor promote blood circulation hot application and to the transfusion induced phlebitis control
CN101647870A (en) * 2009-09-11 2010-02-17 李红 Traditional Chinese medicine for treating phlebitis caused by chemotherapeutics
CN102671054A (en) * 2012-06-12 2012-09-19 赵国藏 Traditional Chinese medicine composition for treating thrombophlebitis
CN102727641A (en) * 2012-07-13 2012-10-17 孙红梅 External traditional Chinese medicine for treating superficial phlebitis

Also Published As

Publication number Publication date
CN103127463A (en) 2013-06-05

Similar Documents

Publication Publication Date Title
CN102961729B (en) Externally-used traditional Chinese medicine for treating varicosity, thromboangiitis obliterans and phlebitis
CN102319327B (en) Traditional Chinese medicine for internally and externally treating diabetic foot
CN101167840B (en) Medicinal composition for treating burns and scald and its preparation method
CN101209337B (en) Medicinal liquor for treating rheumatism and rheumatoid
CN102488879B (en) Medicinal composition for treating rheumatism
CN102091203A (en) External traditional Chinese medicine preparation for treating chronic wounds and preparation method thereof
CN103212040B (en) Chinese medicinal composition for treatment of seborrheic alopecia
CN102847157B (en) Traditional Chinese medicine composition for treating nephropathy through targeted transferring in renal region
CN104398718A (en) Plaster for treating pains in neck, shoulder, waist and legs, and making method thereof
CN103071128B (en) Externally-applied plaster for curing dysmenorrhea
CN101810685A (en) Chinese medicinal composition for treating gonitis and preparation method thereof
CN103341145B (en) Traditional Chinese medicine for treating psoriasis and preparation method thereof
CN101766773A (en) Chinese medicine prescription for treating talagia
CN101347536B (en) External-use preparation for treating traumatic injury
CN103751497A (en) Medicament for treating mastitis and preparation method thereof
CN104666951A (en) Traditional Chinese medicine composition for treating parturient paresis puerperal fever
CN100998838A (en) Chinese medicine for relaxing muscles and tendons to promote blood circulation preparation method thereof
CN104127618A (en) Plaster for treating heumatism
CN101810835A (en) Chinese medicinal composition for treating purpura and preparation method thereof
CN101700386B (en) Traditional Chinese medicine composition resistant to liver cancer and medicine coat thereof
CN102327588A (en) Method for preparing traditional Chinese medicine (TCM) lotion for treating anorexia bedsore
CN101757313B (en) Liquid medicine
CN104383390A (en) Chinese traditional medicine preparation for treating lung cancer
CN102000164B (en) Traditional Chinese medicine composition for treating psoriasis and preparation method thereof
CN102178800B (en) Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
ASS Succession or assignment of patent right

Owner name: ZAOZHUANG MUNICIPAL HOSPITAL

Free format text: FORMER OWNER: NIU YULING

Effective date: 20140409

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: NIU YULING YU QINQIN TO: NIU YULING YU QINQIN JIANG JIFANG XIE XIAOHONG LIU CHANGRUI NIU XINYI

TA01 Transfer of patent application right

Effective date of registration: 20140409

Address after: 277100, No. 41, bibcock Road, Shizhong District, Shandong, Zaozhuang

Applicant after: ZAOZHUANG MUNICIPAL HOSPITAL

Address before: Department of general surgery, Zaozhuang municipal hospital, 41 leading Road, Shizhong District, Shandong, Zaozhuang 277100, China

Applicant before: Niu Yuling

CB03 Change of inventor or designer information

Inventor after: Niu Yuling

Inventor after: Yu Qinqin

Inventor after: Jiang Jifang

Inventor after: Xie Xiaohong

Inventor after: Liu Changrui

Inventor after: Niu Xinyi

Inventor before: Niu Yuling

Inventor before: Yu Qinqin

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140507

Termination date: 20170309

CF01 Termination of patent right due to non-payment of annual fee